Fangbo Cui
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Silk-based biomaterials and applications
- Electrospun Nanofibers in Biomedical Applications
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
- Epigenetics and DNA Methylation 1
-
- Nanoparticle-Based Drug Delivery 2
- Silk-based biomaterials and applications 1
- Co-authors
- Rutian Li (5 shared papers)Xuezhong Du (1 shared paper)Xianfeng Zhang (1 shared paper)Guofeng Yue (4 shared papers)Xiaoping Qian (4 shared papers)Baorui Liu (4 shared papers)Puyuan Wu (4 shared papers)Lixia Yu (4 shared papers)
In The Last Decade
Fangbo Cui
10 papers receiving 388 citations
Peers
Comparison fields: 5 of 65
- Biomaterials 201
- Biomedical Engineering 157
- Molecular Biology 171
- Microbiology 14
- Cancer Research 31
Countries citing papers authored by Fangbo Cui
This map shows the geographic impact of Fangbo Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangbo Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangbo Cui more than expected).
Fields of papers citing papers by Fangbo Cui
This network shows the impact of papers produced by Fangbo Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangbo Cui. The network helps show where Fangbo Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangbo Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 95 | |
| 2 | 2018 | 90 | |
| 3 | 2013 | 66 | |
| 4 | 2013 | 50 | |
| 5 | 2014 | 32 | |
| 6 | 2015 | 28 | |
| 7 | 2017 | 21 | |
| 8 | 2012 | 6 | |
| 9 | 2018 | 6 | |
| 10 | 2016 | 2 |
About Fangbo Cui
Fangbo Cui is a scholar working on Molecular Biology, Biomaterials, Cancer Research, Pulmonary and Respiratory Medicine and Biotechnology, having authored 10 papers that have together received 396 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), Cancer Research and Treatments (3 papers), Nanoplatforms for cancer theranostics (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Epigenetics and DNA Methylation (1 paper), Silk-based biomaterials and applications (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Biomaterials (201 citations), Biomedical Engineering (157 citations), Molecular Biology (171 citations), Microbiology (14 citations) and Cancer Research (31 citations). Fangbo Cui has collaborated with scholars based in China, Hong Kong and Canada. Frequent co-authors include Rutian Li, Xuezhong Du, Xianfeng Zhang, Guofeng Yue, Xiaoping Qian, Baorui Liu, Puyuan Wu, Lixia Yu, Fenglei Wu and Xia Sun. Their work appears in journals such as Cancer Letters, International Journal of Nanomedicine, Laser Physics Letters, Small and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.